Talis Biomedical (TLIS) Competitors $1.41 +0.16 (+12.80%) As of 07/24/2025 09:42 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLIS vs. TBIO, SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, and TTShould you be buying Talis Biomedical stock or one of its competitors? The main competitors of Talis Biomedical include Telesis Bio (TBIO), Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), and Trane Technologies (TT). These companies are all part of the "measuring and control equipment" industry. Talis Biomedical vs. Its Competitors Telesis Bio Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Telesis Bio (NASDAQ:TBIO) and Talis Biomedical (NASDAQ:TLIS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability. Is TBIO or TLIS more profitable? Talis Biomedical has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Telesis Bio's return on equity of 0.00% beat Talis Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Telesis Bio-336.59% N/A -61.89% Talis Biomedical N/A -79.74%-57.16% Do insiders and institutionals have more ownership in TBIO or TLIS? 37.6% of Telesis Bio shares are held by institutional investors. Comparatively, 43.8% of Talis Biomedical shares are held by institutional investors. 24.5% of Telesis Bio shares are held by insiders. Comparatively, 46.0% of Talis Biomedical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the media favor TBIO or TLIS? In the previous week, Telesis Bio's average media sentiment score of 0.00 equaled Talis Biomedical'saverage media sentiment score. Company Overall Sentiment Telesis Bio Neutral Talis Biomedical Neutral Which has more risk and volatility, TBIO or TLIS? Telesis Bio has a beta of 2.89, indicating that its share price is 189% more volatile than the S&P 500. Comparatively, Talis Biomedical has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Which has better valuation and earnings, TBIO or TLIS? Telesis Bio has higher revenue and earnings than Talis Biomedical. Talis Biomedical is trading at a lower price-to-earnings ratio than Telesis Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTelesis Bio$225.09M0.00-$47.72M-$28.200.00Talis Biomedical$300K8.57-$62.01M-$28.02-0.05 SummaryTalis Biomedical beats Telesis Bio on 6 of the 11 factors compared between the two stocks. Get Talis Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for TLIS and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLIS vs. The Competition Export to ExcelMetricTalis BiomedicalAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.57M$1.31M$5.69B$9.50BDividend YieldN/AN/A4.58%4.01%P/E Ratio-0.05N/A28.1020.05Price / Sales8.574.28432.4890.19Price / CashN/AN/A36.2258.56Price / Book0.040.108.665.87Net Income-$62.01M-$54.87M$3.25B$258.55M7 Day Performance12.80%12.80%4.22%3.73%1 Month Performance-1.40%-1.40%10.51%11.75%1 Year Performance-83.07%-83.07%34.40%18.03% Talis Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLISTalis BiomedicalN/A$1.41+12.8%N/A-83.7%$2.57M$300K-0.05260Gap UpTBIOTelesis BioN/A$0.05+105.8%N/A-99.4%$90K$225.09M0.00200Gap UpSMITSchmitt IndustriesN/A$0.02flatN/AN/A$82K$9.89M0.00160SPECSpectaireN/A$0.00+50.0%N/A-99.9%$6KN/A0.008Gap UpTHMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.09+15.1%N/A-22.6%$0.00N/A0.003High Trading VolumePRENWPrenetics GlobalN/A$0.03-27.2%N/A+169.8%$0.00$41.52M0.001Positive NewsGap DownQSIAWQuantum-SiN/A$0.60+0.0%N/AN/A$0.00$3.44M0.00150Positive NewsSMAPWSportsMap Tech AcquisitionN/A$0.04-2.8%N/A+81.8%$0.00N/A0.00N/AGap DownTTTrane Technologies4.5128 of 5 stars$443.47+0.2%$441.40-0.5%+46.6%$98.96B$19.84B36.9245,000Positive NewsUpcoming Earnings Related Companies and Tools Related Companies TBIO Alternatives SMIT Alternatives SPEC Alternatives THMO Alternatives HTGMQ Alternatives OLITW Alternatives PRENW Alternatives QSIAW Alternatives SMAPW Alternatives TT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLIS) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talis Biomedical Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talis Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLIS Stock Alerts